Related references
Note: Only part of the references are listed.Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial
Claus Yding Andersen et al.
HUMAN REPRODUCTION (2015)
Review: hCGs: Different sources of production, different glycoforms and functions
T. Fournier et al.
PLACENTA (2015)
Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement
John L. Yovich et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2015)
Improving the luteal phase after ovarian stimulation: reviewing new options
C. Yding Andersen et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2014)
Too much of a good thing? Experimental evidence suggests prolonged exposure to hCG is detrimental to endometrial receptivity
Jemma Evans et al.
HUMAN REPRODUCTION (2013)
GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients
P. Humaidan et al.
HUMAN REPRODUCTION (2013)
hCG, five independent molecules
Laurence A. Cole
CLINICA CHIMICA ACTA (2012)
A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization
L. L. Thuesen et al.
HUMAN REPRODUCTION (2012)
Hyperglycosylated hCG and pregnancy failures
Laurence A. Cole
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2012)
hCG, the wonder of today's science
Laurence A. Cole
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2012)
A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study
Evangelos G. Papanikolaou et al.
FERTILITY AND STERILITY (2011)
GnRH agonist for triggering of final oocyte maturation: time for a change of practice?
P. Humaidan et al.
HUMAN REPRODUCTION UPDATE (2011)
Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support
J. C. Castillo et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2010)
Identification of the High-Risk Patient for Ovarian Hyperstimulation Syndrome
Evangelos G. Papanikolaou et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2010)
Prevention of OHSS
Mohamed Aboulghar
REPRODUCTIVE BIOMEDICINE ONLINE (2009)
Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study
P. Humaidan et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2006)
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
EG Papanikolaou et al.
FERTILITY AND STERILITY (2006)
A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists
EM Kolibianakis et al.
HUMAN REPRODUCTION (2005)
GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles:: a prospective randomized study
P Humaidan et al.
HUMAN REPRODUCTION (2005)
Distinction between early and late ovarian hyperstimulation syndrome
RS Mathur et al.
FERTILITY AND STERILITY (2000)
Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women
H Levine et al.
FERTILITY AND STERILITY (2000)
Share Paper
